San Francisco Business Times FibroGen Inc. will pay $10 million to terminate its 234,200-square-foot office lease at 409 Illinois St. in San Francisco. The drug maker’s lease was to run through 2028. Its lease now will be terminated effective at the end of this year. But over the summer, the company said it would need […]

The post Drug Maker Paying $10Mln to Exit San Francisco Office Lease appeared first on Commercial Real Estate Direct.